OSWEGO, N.Y. — Oswego Health says it has purchased the cobas 5800 System, which it describes as a fully automated molecular laboratory instrument.
It offers a flexible PCR testing product to enable “accurate and reliable” diagnosis of infectious diseases, including chlamydia, gonorrhea, COVID-19, and HPV testing, Oswego Health said in its Wednesday announcement.
The system is built to offer a fully automated workflow and offers an expanded onboard capacity, allowing labs to test multiple assays simultaneously. It takes about 2.5 hours to produce the first 24 results. With 24 more results ready every 60 minutes thereafter, cobas 5800 has the capability of delivering up to 144 results in 8 hours.
(Sponsored)
Mergers and Acquisitions of Architectural and Engineering Firms
The pace of mergers and acquisitions (M&A) in the Architectural and Engineering (A/E) industry is at an all-time high, driven by firms seeking new opportunities for growth. From 2023 to
Future-Proof Your Hiring Strategy
Struggling to find the right talent — or keep it? You’re not alone. Across industries, employers are feeling the pressure of a widening skills gap, high turnover, and increasing competition
Oswego Health says it’s the fourth health-care system in the country to purchase the cobas 5800 System.
